1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Drugs In Development, 2022, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in later stages of the disease. The signs and symptoms include persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody phlegm or spit (sputum), fatigue and weakness and unintentional weight loss. The disease might be controlled with the help of medications, chemotherapy and modifications in lifestyle.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Non-Small Cell Lung Cancer - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Non-Small Cell Lung Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Non-Small Cell Lung Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Small Cell Lung Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 20, 1, 98, 452, 400, 56, 319, 75 and 12 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 1, 12, 19, 6, 41 and 4 molecules, respectively.
Non-Small Cell Lung Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Small Cell Lung Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Non-Small Cell Lung Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Non-Small Cell Lung Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Non-Small Cell Lung Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Non-Small Cell Lung Cancer (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Non-Small Cell Lung Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Non-Small Cell Lung Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Non-Small Cell Lung Cancer - Overview
- Non-Small Cell Lung Cancer - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Non-Small Cell Lung Cancer - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Non-Small Cell Lung Cancer - Companies Involved in Therapeutics Development
- Non-Small Cell Lung Cancer - Drug Profiles
- Non-Small Cell Lung Cancer - Dormant Projects
- Non-Small Cell Lung Cancer - Discontinued Products
- Non-Small Cell Lung Cancer - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact the Publisher
- Disclaimer
- Number of Products under Development for Non-Small Cell Lung Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Non-Small Cell Lung Cancer - Dormant Projects, 2022
- Non-Small Cell Lung Cancer - Discontinued Products, 2022
- Number of Products under Development for Non-Small Cell Lung Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3SBio Inc
- 4D Pharma Plc
- 4SC AG
- A&G Pharmaceutical Inc
- A. Menarini Industrie Farmaceutiche Riunite Srl
- A2i Therapeutics Ltd
- Aadi Bioscience Inc
- Abbisko Therapeutics Co Ltd
- AbbVie Inc
- Abion Inc
- ABL Bio Inc
- ABM Therapeutics Inc
- AbTis Co Ltd
- AC Bioscience SA
- Acepodia Inc
- Achilles Therapeutics Plc
- AcuityBio Corp
- Adagene Suzhou Ltd
- Adaptimmune Therapeutics Plc
- ADC Therapeutics SA
- Adlai Nortye Biopharma Co Ltd
- Advanced BioDesign
- Advenchen Laboratories LLC
- Adze Biotechnology Inc
- Affimed GmbH
- Agenus Inc
- Agilvax Inc
- AI Therapeutics Inc
- Akeso Inc
- Alaunos Therapeutics Inc
- Alethia Biotherapeutics Inc
- Alkermes Plc
- Alligator Bioscience AB
- Allist Shanghai Pharmaceutical Technology Co Ltd
- Almac Discovery Ltd
- Alpha Biopharma Ltd
- Alphageneron-Pharmaceuticals Inc
- Alphamab Oncology
- Alpine Immune Sciences Inc
- Ambrx Biopharma Inc
- Amgen Inc
- Aminex Therapeutics Inc
- AmMax Bio Inc
- Amphivena Therapeutics Inc
- Anagenics Ltd
- Anaveon AG
- AnBogen Therapeutics
- AnHeart Therapeutics Inc
- Anhui Anke Biotechnology (Group) Co Ltd
- Ansun Biopharma Inc
- Antapodia Therapeutics Inc
- Antengene Corp Ltd
- Antibody Therapeutics Inc
- AP Biosciences Inc
- Apexigen Inc
- Apollomics Inc
- Applied Pharmaceutical Science Inc
- Applied Research using OMIC Sciences SL
- Aprea Therapeutics Inc
- Aravive Inc
- Arbella Therapeutics LLC
- Arch Oncology Inc
- Arcus Biosciences Inc
- Ardan Pharma
- Ariz Precision Medicine Inc
- Aro Biotherapeutics Co
- Arthrosi Therapeutics Inc
- Arvinas Inc
- Asana BioSciences LLC
- Ascenta Therapeutics Inc
- Ascentage Pharma Group International
- Ascentawits Pharmaceuticals Ltd
- Ascentgene Inc
- Aslan Pharmaceuticals Ltd
- Astellas Pharma Inc
- Astex Pharmaceuticals Inc
- AstraZeneca Plc
- Atreca Inc
- aTyr Pharma Inc
- Aulos Bioscience Inc
- AUM Biosciences Pte Ltd
- Aurigene Discovery Technologies Ltd
- Aurobindo Pharma Ltd
- Avacta Life Sciences Ltd
- AvenCell Europe GmbH
- Avesthagen Ltd
- Axelar AB
- Baobab AiBIO Co Ltd
- Base Therapeutics
- Basilea Pharmaceutica Ltd
- Bavarian Nordic AS
- Bayer AG
- BeiGene Ltd
- Beijing Anshi Biotechnology Co Ltd
- Beijing Biostar Technologies Ltd
- Beijing Eastern Biotech Co Ltd
- Beijing Hanmi Pharmaceutical Co Ltd
- Beijing Jingda Biotechnology Co Ltd
- Beijing Konruns Pharmaceutical Co Ltd
- Beijing Mabworks Biotech Co Ltd
- Beijing Pearl Biotechnology LLC
- Beijing Scitech-MQ Pharmaceuticals Ltd
- BerGenBio ASA
- Beta Pharma Inc
- Betta Pharmaceuticals Co Ltd
- Better Life Pharmaceuticals Inc
- BeyondSpring Inc
- Bicycle Therapeutics Plc
- Bika Biotechnology Guanzhou Co Ltd
- BIMINI Biotech BV
- Binjiang Pharma, Inc.
- Bio-Path Holdings Inc
- Bio-Synectics Inc
- Bio-Thera Solutions Ltd
- Bio4t2 LLC
- BioAtla Inc
- Biocad
- Biohaven Pharmaceutical Holding Company Ltd
- BioIntegrator
- BioInvent International AB
- BioMarck Pharmaceuticals Ltd
- Biomea Fusion Inc
- BioMed Valley Discoveries Inc
- BiOneCure Therapeutics Inc
- BioNTech SE
- Biosion Inc
- Biosplice Therapeutics Inc
- Biotheus Inc
- Bioven Group
- Bioviz Technologies Pvt Ltd
- BioXpress Therapeutics SA
- BJ Bioscience Inc
- Black Diamond Therapeutics Inc
- Blueprint Medicines Corp
- Boehringer Ingelheim International GmbH
- Bolt Biotherapeutics Inc
- Boston Pharmaceuticals Inc
- BoYen Therapeutics Inc
- BriaCell Therapeutics Corp
- Bridge Biotherapeutics Inc
- BridgeBio Pharma Inc
- BrightGene Bio-Medical Technology Co Ltd
- Bristol-Myers Squibb Co
- C4 Therapeutics Inc
- Calico Life Sciences LLC
- Calithera Biosciences Inc
- CanBas Co Ltd
- Candel Therapeutics Inc
- Cantargia AB
- Cascade Prodrug Inc
- Catalym GmbH
- Cellatoz Therapeutics Inc
- CellCentric Ltd
- Celldex Therapeutics Inc
- Cellestia Biotech AG
- Celltrion Inc
- Cellular Biomedicine Group Inc
- Cellworks Group Inc
- Celularity Inc
- Centaurus Biopharma Co Ltd
- Centurion BioPharma Corp
- Checkpoint Therapeutics Inc
- Chengdu Di'ao Pharmaceutical Group Co Ltd
- Chengdu Huajian Future Science And Technology Co Ltd
- Chengdu Huitai Biomedicine Co Ltd
- Chengdu Jinrui Foundation Biotechnology Co Ltd
- Chengdu Yongkang Pharmaceutical Co Ltd
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- China Resources Pharmaceutical Group Ltd
- Chinook Therapeutics Inc
- Chiome Bioscience Inc
- Chong Kun Dang Pharmaceutical Corporation
- Chugai Pharmaceutical Co Ltd
- Cipla BioTec Pvt Ltd
- Cloaked Therapeutics LLC
- Clonz Biotech Pvt Ltd
- Clovis Oncology Inc
- Co-D Therapeutics Inc
- Codiak BioSciences Inc
- Compass Therapeutics Inc
- Compugen Ltd
- Corcept Therapeutics Inc
- Cortice Biosciences Inc
- Corvus Pharmaceuticals Inc
- Cothera Bioscience Pty Ltd
- Cotinga Pharmaceuticals Inc
- CSPC Pharmaceutical Group Ltd
- CStone Pharmaceuticals Co Ltd
- CTCELLS Inc
- Cullgen Inc
- Cullinan Oncology Inc
- Cureport Inc
- Curis Inc
- Cyclacel Pharmaceuticals Inc
- Cyclica Inc
- Cyrus Therapeutics Inc
- Cytocraft Bio-Tech Development Co Ltd
- CytoImmune Therapeutics Inc
- CytomX Therapeutics Inc
- D3 Bio Inc
- Daiichi Sankyo Co Ltd
- Deciphera Pharmaceuticals Inc
- DEKK-TEC Inc
- Delta-Fly Pharma Inc
- Denovo Biopharma LLC
- DexTech Medical AB
- DiNonA Inc
- Dizal (Jiangsu) Pharmaceutical Co Ltd
- Dracen Pharmaceuticals Inc
- Dragonfly Therapeutics Inc
- Duality Biologics (Shanghai) Co Ltd
- Duo Oncology Inc
- Dyadic International Inc
- DynamiCure Biotechnology LLC
- Eden Biologics Inc
- Edison Oncology Holding Corp
- eFFECTOR Therapeutics Inc
- EirGenix Inc
- Eisai Co Ltd
- Eleison Pharmaceuticals LLC
- Eli Lilly and Co
- Elicio Therapeutics Inc
- Ella Therapeutics Ltd
- Elpiscience Biopharma Ltd
- Elucida Oncology Inc
- Enhancedbio Inc
- Enliven Therapeutics Inc
- Enzene Biosciences Ltd
- EpicentRx Inc
- EpimAb Biotherapeutics Inc
- Epizyme Inc
- Epygen Biotech Pvt Ltd
- Erasca Inc
- Esanex Inc
- Etern BioPharma Co Ltd
- Euclises Pharmaceuticals Inc
- Eucure (Beijing) Biopharma Co Ltd
- Eudendron Srl
- Eureka Therapeutics Inc
- Eutilex Co Ltd
- Evaxion Biotech ApS
- Evestra Inc
- Evotec SE
- Exeliom Biosciences SAS
- Exelixis Inc
- F-star Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- Fannin Innovation Studio
- Faron Pharmaceuticals Oy
- Fate Therapeutics Inc
- Felicitex Therapeutics Inc
- FibroStatin SL
- Flame Biosciences Inc
- Fochon Pharmaceutical Ltd
- Foghorn Therapeutics Inc
- Formosa Pharmaceuticals Inc
- Foshan Rexie Biotechnology Co Ltd
- Fujifilm Holdings Corp
- Fulgent Pharma LLC
- Future Medicine Co Ltd
- G&E Herbal Biotechnology Co., Ltd.
- G1 Therapeutics Inc
- GAiA BioMedicine Inc
- Galectin Therapeutics Inc
- Galecto Inc
- Galera Therapeutics Inc
- Gan & Lee Pharmaceuticals Co Ltd
- Gedeon Richter Plc
- GeneCraft Inc
- Genelux Corp
- Genentech USA Inc
- Geneos Therapeutics Inc
- GeneQuantum Healthcare Suzhou Co Ltd
- Generium
- Generos Biomedical Technology (Hangzhou) Co Ltd
- GeneScience Pharmaceuticals Co Ltd
- Genexine Inc
- GenFleet Therapeutics (Shanghai) Inc
- Genmab AS
- Genocea Biosciences Inc
- GenoImmune Therapeutics Biotechnology Co Ltd
- Genome & Co
- Genor BioPharma Co Ltd
- Genosco Inc
- Genprex Inc
- Gensun Biopharma Inc
- Gilead Sciences Inc
- GLG Pharma SA
- GlycaNova AS
- GlycoNex Inc
- Glycotope GmbH
- Golden Biotechnology Corp
- Gradalis Inc
- Grid Therapeutics LLC
- Gritstone Bio Inc
- GSK plc
- GT Biopharma Inc
- Guangdong Yinzhu Pharmaceutical Technology Co Ltd
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou Anjie Biomedical Technology Co Ltd
- Guangzhou BeBetter Medicine Technology Co Ltd
- Guangzhou Bio-gene Technology Co Ltd
- Guangzhou DM Intelligence Ltd
- Guangzhou Doublle Bioproduct Inc
- Guangzhou Sinogen Pharmaceutical Co Ltd
- Guangzhou Yinming Biomedical Technology Co Ltd
- HaimBio Ltd
- Hainan Yuekang Biological Medicine Co Ltd
- Handok Inc
- Hangzhou DAC Biotech Co Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hangzhou Zenshine Pharmaceuticals Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harbour BioMed (Guangzhou) Co Ltd
- Harmonic Pharma
- HEC Pharma Co Ltd
- Hefei Hankemab Biotechnology Co Ltd
- Helix BioPharma Corp
- Helsinn Group
- Henan Genuine Biotech Co Ltd
- Henan Topfond Pharmaceutical TCM Co Ltd
- Hibercell Inc
- HiFiBiO Therapeutics Inc
- Highlight Therapeutics SL
- HitGen Inc
- Hope Biosciences LLC
- Horizon Therapeutics Plc
- Huabo Biopharm (Shanghai) Co Ltd
- Huadong Medicine Co Ltd
- Huahui Anjian (Beijing) Biotechnology Co Ltd
- Hualan Biological Engineering Inc
- Hubei Soundny Bio-Tech Co Ltd
- Humanwell Healthcare Group Co Ltd
- Hummingbird Bioscience Pte Ltd
- Hutchison MediPharma Ltd
- I-Mab
- iCeutica Inc
- Ideaya Biosciences Inc
- Idera Pharmaceuticals Inc
- Ikena Oncology Inc
- Imhotep Diagnostics & Therapeutics Ltd
- Immuneering Corp
- ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
- ImmuneSensor Therapeutics Inc
- ImmuNext Inc
- Immunitas Therapeutics Inc
- ImmunityBio Inc
- Immunocore Holdings Plc
- ImmunoGen Inc
- Immunophotonics Inc
- ImmunSYS Inc
- Immutep Ltd
- Immvira Co Ltd
- Imugene Ltd
- IMV Inc
- Incyte Corp
- Infinity Pharmaceuticals Inc
- Inflection Biosciences Ltd
- Inhibrx Inc
- Inmune Bio Inc
- Innate Pharma SA
- Inner Mongolia Qite Biotechnology (Group) Co Ltd
- InnoCare Pharma Ltd
- InnoCure Therapeutics Inc
- Innovative Cellular Therapeutics Co Ltd
- Innovent Biologics Inc
- Inspirna Inc
- Instil Bio Inc
- Insud Pharma
- InteRNA Technologies BV
- Intima Bioscience Inc
- Intocell Inc
- InventisBio Co Ltd
- Inventiva SA
- InxMed (Beijing) Co Ltd
- IO Biotech Inc
- Io Therapeutics Inc
- iOnctura SA
- Iovance Biotherapeutics Inc
- Ipsirius SAS
- ISU ABXIS Co Ltd
- iTeos Therapeutics Inc
- Iterion Therapeutics Inc
- ITM Isotope Technologies Munich SE
- Ivy Life Sciences Co Ltd
- J Ints Bio Co Ltd
- Jacobio Pharmaceuticals Group Co Ltd
- Janux Therapeutics Inc
- Jazz Pharmaceuticals Plc
- Jiangsu Aidea Pharmaceutical Co Ltd
- Jiangsu Aosaikang Pharmaceutical Co Ltd
- Jiangsu Carephar Pharmaceutical Co Ltd
- Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
- Jiangsu Hansoh Pharmaceutical Group Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Maidu Drug Research and Development Co Ltd
- Jiangsu Suzhong Pharmaceutical Group Co Ltd
- Jiangsu Wuzhong Pharmaceutical Group Co Ltd
- Jiangsu Zhengda Fenghai Pharmaceutical Co Ltd
- Jiangxi Jemincare Group Co Ltd
- Jiangxi Qingfeng Pharmaceutical Co Ltd
- Jing Medicine Technology Shanghai Ltd
- Johnson & Johnson
- Jounce Therapeutics Inc
- JS InnoPharm (Shanghai) Ltd
- JSK Therapeutics Inc
- JSR Life Sciences LLC
- Jubilant Therapeutics Inc
- Kadmon Holdings Inc
- KAHR medical Ltd
- Kairos Pharma Ltd
- Kanaph Therapeutics Inc
- Karyo Biologics LLC
- Karyopharm Therapeutics Inc
- Kidswell Bio Corp
- Kineta Inc
- Kinnate Biopharma Inc
- Kirilys Therapeutics Inc
- Kiromic BioPharma Inc
- Kronos Bio Inc
- Kura Oncology Inc
- Kymab Ltd
- Kymera Therapeutics Inc
- L&L Biopharma Co Ltd
- L.E.A.F. Pharmaceuticals LLC
- LaNova Medicines Ltd
- Lantern Pharma Inc
- LATITUDE Pharmaceuticals Inc
- Le Sun Pharmaceuticals Ltd
- Legend Biotech Corp
- LegoChem Biosciences Inc
- Lepu Biopharma Co Ltd
- Les Laboratoires Servier SAS
- Levim Biotech LLP
- LIfT BioSciences Ltd
- Light Chain Bioscience
- Lime Therapeutics Inc
- Lineage Cell Therapeutics Inc
- Linnaeus Therapeutics Inc
- Lipomedics Ltd
- LipoSeuticals Inc
- Livzon Pharmaceutical Group Co Ltd
- Lixte Biotechnology Holdings Inc
- Lotus Pharmaceutical Co Ltd
- Loxo Oncology Inc
- Lupin Ltd
- Luye Pharma Group Ltd
- Lycera Corp
- Lyell Immunopharma Inc
- Lyvgen Biopharma Ltd
- Mabpharm Ltd
- Mabwell Shanghai Bioscience Co Ltd
- Machavert Pharmaceuticals LLC
- MacroGenics Inc
- MAIA Biotechnology Inc
- Marengo Therapeutics Inc
- Maverick Therapeutics Inc
- MaxiVAX SA
- MedAbome Inc
- Medical Guidance Systems LLC
- Medicenna Therapeutics Corp
- MedPacto Inc
- Memgen Inc
- Merck & Co Inc
- Merck KGaA
- Mereo Biopharma Group Plc
- Mersana Therapeutics Inc
- Merus NV
- Meryx Inc
- Metaclipse Therapeutics Corp
- METiS Therapeutics Inc
- Microbio Co Ltd
- Microbiotica Ltd
- Midissia Therapeutics Inc
- Millennium Pharmaceuticals Inc
- MiNK Therapeutics Inc
- Mirati Therapeutics Inc
- Moderna Inc
- Modra Pharmaceuticals BV
- Molecular Partners AG
- Molecular Targeting Technologies Inc
- Molecular Templates Inc
- Monte Rosa Therapeutics Inc
- Morvus Technology Ltd
- Multitude therapeutics Inc
- Mycenax Biotech Inc
- MyeloRx LLC
- Nalo Therapeutics Inc
- Nanjing CART Medical Technology Co Ltd
- Nanjing Sanhome Pharmaceutical Co Ltd
- Nanobiotix SA
- Nanology LLC
- NantBioScience Inc
- Natsar Pharmaceuticals Inc
- Navire Pharma Inc
- Navrogen Inc
- Nektar Therapeutics
- Nemucore Medical Innovations Inc
- NeoTX Therapeutics Ltd
- Netris Pharma SAS
- Neumedicines Inc
- New Beta Innovation Ltd
- Newish Technology Beijing Co Ltd
- NEX-I Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- NH TherAguix SAS
- NightHawk Biosciences Inc
- Ningbo Wenda Pharmaceutical Technology Co Ltd
- Nitto BioPharma Inc
- NKGen Biotech Inc
- Nouscom AG
- Novartis AG
- Noxopharm Ltd
- NuCana Plc
- Numab Therapeutics AG
- Nurix Therapeutics Inc
- Nuvalent Inc
- OBI Pharma Inc
- OBiO Technology (Shanghai) Corp Ltd
- Obsidian Therapeutics Inc
- Ocean Biomedical Inc
- Ocellaris Pharma Inc
- Ocuphire Pharma Inc
- Omega Therapeutics Inc
- Oncobix Co Ltd
- OncoC4 Inc
- Oncolys BioPharma Inc
- Oncomatryx Biopharma SL
- Onconic Therapeutics Co Ltd
- Onconova Therapeutics Inc
- OncoResponse Inc
- Oncorus Inc
- OncoTrap Inc
- OncXerna Therapeutics Inc
- Oneness Biotech Co Ltd
- ONK Therapeutics Ltd
- Ono Pharmaceutical Co Ltd
- Onxeo SA
- Ophelos Therapeutics Pty Ltd
- Orano Med LLC
- Origincell Technology Group Co Ltd
- Oryx GmbH & Co KG
- OSE Immunotherapeutics SA
- OtiTopic Inc
- Otsuka Pharmaceutical Co Ltd
- Outlook Therapeutics Inc
- Oxford BioTherapeutics Ltd
- Oxford Vacmedix UK Ltd
- P&PMed Shanghai Biotechnology Co Ltd
- Pacylex Pharmaceuticals Inc
- Palleon Pharmaceuticals Inc
- Palo BioFarma SL
- Panbela Therapeutics Inc
- Partner Therapeutics Inc
- PDC Line Pharma SAS
- PDS Biotechnology Corp
- PeLeMed Co Ltd
- Penrose Therapeutix LLC
- Peptomyc SL
- Perturba Therapeutics Inc
- Pfizer Inc
- Pharma Mar SA
- Philogen SpA
- PHusis Therapeutics Inc
- Pinetree Therapeutics Inc
- PlantForm Corp
- Plexium Inc
- Plus Therapeutics Inc
- PlusVitech SL
- PNB Vesper Life Science Pvt Ltd
- Polaris Pharmaceuticals Inc
- Portage Biotech Inc
- Poseida Therapeutics Inc
- Potenza Therapeutics Inc
- Precision Biologics Inc
- Precision Biotechnology Co Ltd
- Prelude Therapeutics Inc
- Prestige BioPharma Ltd
- Primevax Immuno Oncology Inc
- ProfoundBio Suzhou Co Ltd
- Promontory Therapeutics Inc
- Propanc Biopharma Inc
- Protgen Ltd
- PsiOxus Therapeutics Ltd
- Puma Biotechnology Inc
- Pure Biologics SA
- Purple Biotech Ltd
- Pyxis Oncology Inc
- Qilu Pharmaceutical Co Ltd
- Qingdao Sino-Cell Biomedicine Co Ltd
- Qu Biologics Inc
- Qurient Co Ltd
- R-Pharm
- Radiopharm Theranostics Ltd
- Rapa Therapeutics LLC
- RAPT Therapeutics Inc
- RaQualia Pharma Inc
- Reata Pharmaceuticals Inc
- Recombio SL
- Recursion Pharmaceuticals Inc
- RedCloud Bio Inc
- RedHill Biopharma Ltd
- Regeneron Pharmaceuticals Inc
- ReguGene Co Ltd
- RemeGen Co Ltd
- Repare Therapeutics Inc
- Repertoire Immune Medicines Inc
- Replimune Ltd
- Reven Holdings Inc
- Revolution Medicines Inc
- Rhizen Pharmaceuticals SA
- Roivant Sciences Ltd
- Rophibio Inc
- RS Research
- Sagimet Biosciences Inc
- Salubris Biotherapeutics Inc
- Sanofi
- Scancell Holdings Plc
- Scholar Rock Inc
- ScinoPharm Taiwan Ltd
- Scorpion Therapeutics Inc
- Seagen Inc
- SELLAS Life Sciences Group Inc
- Sensei Biotherapeutics Inc
- Sentinel Oncology Ltd
- Seven and Eight Biopharmaceuticals Corp
- Shandong Boan Biotechnology Co Ltd
- Shandong Buchang Pharmaceutical Co Ltd
- Shandong New Time Pharmaceutical Co Ltd
- Shanghai Affinity Biomedical Technology Co Ltd
- Shanghai Biomed-Union Biotechnology Co Ltd
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Escugen Biotechnology Co Ltd
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
- Shanghai Gefeimu Biomedical Technology Co Ltd
- Shanghai Gencells Therapeutics Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Henlius Biotech Inc
- Shanghai Houchao Biotechnology Co Ltd
- Shanghai Hui Dong Biotechnology Co Ltd
- Shanghai Institute of Biological Products Co Ltd
- Shanghai Jiyu Pharmaceutical Technology Co Ltd
- Shanghai Junshi Bioscience Co Ltd
- Shanghai Miracogen Inc
- Shanghai Novamab Biopharmaceuticals Co Ltd
- Shanghai Pharmaceutical Group Co Ltd
- Shanghai Yidian Pharmaceutical Technology Development Co Ltd
- Shanghai Yingli Pharmaceutical Co Ltd
- Shenogen Pharma Group Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shenzhen Forward Pharmaceutical Co Ltd
- Shenzhen Neptunus Institute of Pharmaceutical Technology Co Ltd
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Shenzhen Targetrx Inc
- Shijiazhuang Yiling Pharmaceutical Co Ltd
- Shionogi & Co Ltd
- Shouyao Holding Co Ltd
- Sichuan J.Z. Bio-chemical Science and Technology Development Co Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
- Signablok Inc
- SignalChem Lifesciences Corp
- SignPath Pharma Inc
- Sihuan Pharmaceutical Holdings Group Ltd
- Simcere Pharmaceutical Group Ltd
- Simcha Therapeutics Inc
- Singh Biotechnology LLC
- Sino Biopharmaceutical Ltd
- SinoCelltech Group Ltd
- Sirnaomics Ltd
- SiVEC Biotechnologies LLC
- SK Life Science Inc
- Smerud Medical Research International AS
- Sonnet BioTherapeutics Holdings Inc
- Sonoval LLC
- Soricimed Biopharma Inc
- Sorrento Therapeutics Inc
- Sosei Group Corp
- SOTIO Biotech AS
- Specific Biologics Inc
- Sphaera Pharma Pte Ltd
- SpringWorks Therapeutics Inc
- ST Pharm Co Ltd
- Starpharma Holdings Ltd
- STAT3 Therapeutics Inc
- Statera Biopharma Inc
- Stcube Inc
- Stemirna Therapeutics Ltd
- Stemsynergy Therapeutics Inc
- Sumitomo Dainippon Pharma Oncology, Inc
- Sumitomo Pharma Co Ltd
- Shenghe (China) Biopharmaceutical Co Ltd
- Suntec Medical (Taiwan) Inc
- SupremeCure Pharma Inc
- Surface Oncology Inc
- Sutro Biopharma Inc
- SuviCa Inc
- Suzhou BlueHorse Therapeutics Co Ltd
- Suzhou Dingfu Target Biotechnology Co Ltd
- Suzhou GenHouse Pharmaceutical Co Ltd
- Suzhou Maximum Bio-tech Co Ltd
- Suzhou Medilink Therapeutics Ltd
- Suzhou Neupharma Co Ltd
- Suzhou Shengdia Biomedical Co Ltd
- Suzhou Stainwei Biotech Inc
- Suzhou Teligene Ltd
- Suzhou Zelgen Biopharmaceutical Co Ltd
- Suzhou Zerun New Drug Research and Development Co Ltd
- Symphogen A/S
- Synactix Pharmaceuticals Inc
- Syncromune Inc
- SynDevRx Inc
- Synermore Biologics Co Ltd
- Synthekine Inc
- Syntrix Pharmaceuticals
- Systimmune Inc
- T-Cure Bioscience Inc
- Tactical Therapeutics Inc
- Taiho Oncology Inc
- Taiho Pharmaceutical Co Ltd
- Taizhou Maibotek Biotechnology Co Ltd
- Takeda Pharmaceutical Co Ltd
- Tango Therapeutics Inc
- Tasly Pharmaceutical Group Co Ltd
- Tavotek Biotherapeutics
- TCR2 Therapeutics Inc
- Teclison Ltd
- Tempest Therapeutics Inc
- Teon Therapeutics Inc
- Tetranov International Inc
- Tevogen Bio Inc
- Therabest Co Ltd
- Theralase Technologies Inc
- Therapex Corp
- Theseus Pharmaceuticals Inc
- Tianjin Chase Sun Pharmaceutical Co Ltd
- Tianjin Hemay Pharmaceutical Co Ltd
- Tianjin Hengjia Biotechnology Development Co Ltd
- TILT Biotherapeutics Ltd
- Tiziana Life Sciences Plc
- Tizona Therapeutics Inc
- Tmunity Therapeutics Inc
- TOLREMO Therapeutics AG
- TOT Biopharm Co Ltd
- TRACON Pharmaceuticals Inc
- Transcenta Holding Ltd
- Treadwell Therapeutics Inc
- Triumvira Immunologics Inc
- TScan Therapeutics Inc
- Turning Point Therapeutics Inc
- Turnstone Biologics Inc
- Tvardi Therapeutics Inc
- Twinpigbiolab Co Ltd
- TYK Medicines Inc
- Tyme Inc
- Tyra Biosciences Inc
- UbiVac Inc
- Ultimovacs AS
- United BioPharma Inc
- United Immunity Co Ltd
- Vaccinex Inc
- Vaccitech Plc
- Valo Therapeutics Oy
- VasGene Therapeutics Inc
- Vault Pharma Inc
- Vaximm AG
- Vaxon Biotech
- Venus Remedies Ltd
- Verastem Inc
- VITRAC Therapeutics LLC
- Vivacitas Oncology Inc
- Voronoi Group
- VREX Therapeutics Inc
- Vyriad Inc
- Wayshine Biopharma Inc
- WellMarker Bio Co Ltd
- Western Oncolytics Ltd (Inactive)
- Wigen Biomedicine Technology (Shanghai) Co Ltd
- WindMIL Therapeutics Inc
- Wuxi Shuangliang Biotechnology Co Ltd
- Xbiome Co Ltd
- Xbrane Biopharma AB
- Xcovery Holding Co LLC
- Xencor Inc
- Xiangxue Life Sciences
- Xiconic Pharmaceuticals LLC
- Xilio Therapeutics Inc
- XuanZhu Biological Technology Co Ltd
- Xynomic Pharmaceuticals Holdings Inc
- Y-Biologics Inc
- Yangtze River Pharmaceutical Group
- Yooyoung Pharm Co Ltd
- Yuhan Corp
- Zelluna Immunotherapy AS
- Zentalis Pharmaceuticals Inc
- Zhejiang Bossan Pharmaceutical Co Ltd
- Zhejiang Hisun Pharmaceutical Co Ltd
- Zhejiang Jianfeng Group Company Ltd
- Zhejiang Landun Pharmaceutical Co Ltd
- Zhejiang Teruisi Pharmaceutical Co Ltd
- Zhejiang Yangshengtang Biotech Co Ltd
- Zhuhai Beihai Biotech Co Ltd
- Zhuhai GRIT biotechnology Inc
- Zucero Therapeutics Ltd
- Zymeworks Inc
